相关实验视频
Updated: May 28, 2025

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
101
眼科中的黄素:机制,挑战和新兴机会
Adriana Ribeiro1, Daniele Oliveira2, Helena Cabral-Marques1
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
Molecules (Basel, Switzerland)
|February 13, 2025
概括
黄素在治疗眼睛疾病方面表现有前途,但运输不良限制了其使用. 像纳米颗粒和凝这样的先进的输送系统正在改善它对各种眼睛疾病的有效性.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
背景情况:
- 在全球范围内,眼部疾病是导致视力丧失的主要原因.
- 黄素是一种天然的多,具有有益的抗炎,抗氧化和神经保护性质,用于治疗眼睛疾病.
- 库尔库明的临床应用受到溶解性差,生物可用性和快速消除的限制.
研究的目的:
- 审查眼科治疗的黄素输送系统的进展.
- 突出克服黄素的药理动力学限制的策略.
- 探索黄素在前后段眼部疾病中的治疗潜力.
主要方法:
- 对新兴的黄素输送平台 (proniosomal凝,转移体,环极素复合物,纳米粒子,水凝) 的审查.
- 对作用机制的分析,包括NF-κB和TLR4通路的调节.
- 在前部 (角膜炎,干眼) 和后部 (糖尿病视网膜病变,AMD) 细分疾病中应用的评估.
主要成果:
- 新的输送系统增强了黄素的可溶性,透性和眼睛保留.
- 纳米颗粒载体促进持续释放和针对性传递后部疾病.
- 循环德克斯和粘膜系统改善角膜透和保留前部疾病.
- 黄素有效调节关键的炎症和氧化应激通路.
结论:
- 先进的黄素输送系统显示出治疗各种眼部疾病的巨大潜力.
- 这些策略解决了药理动力学挑战,为临床转化铺平了道路.
- 进一步的临床试验对于验证黄素在眼科治疗中的安全性和有效性至关重要.
相关概念视频
Glaucoma: Overview
496
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
496
Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386

